Tritsch, E., Mallat, Y., Lefebvre, F., Diguet, N., Escoubet, B., Blanc, J., De Windt, L. J., Catalucci, D., Vandecasteele, G., Li, Z., & Mericskay, M. (2013). An SRF/miR-1 axis regulates NCX1 and Annexin A5 protein levels in the normal and failing heart. Cardiovascular Research, 98(3), 372-380. https://doi.org/10.1093/cvr/cvt042

Huijts, M., van Oostenbrugge, R. J., Duits, A., Burkard, T., Muzzarelli, S., Maeder, M. T., Schindler, R., Pfisterer, M. E., & Brunner-La Rocca, H.-P. (2013). Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial. European journal of heart failure, 15(6), 699-707. https://doi.org/10.1093/eurjhf/hft020

Daskalopoulos, E. P., Hermans, K. C. M., Janssen, B. J. A., & Blankesteijn, W. M. (2013). Targeting the Wnt/frizzled signaling pathway after myocardial infarction: A new tool in the therapeutic toolbox?Trends in Cardiovascular Medicine, 23(4), 121-127. https://doi.org/10.1016/j.tcm.2012.09.010

Stapf, D., Franke, A., Schreckenberg, M., Schummers, G., Mischke, K., Marx, N., Schauerte, P., & Knackstedt, C. (2013). Beat to beat 3-dimensional intracardiac echocardiography: theoretical approach and practical experiences. International Journal of Cardiovascular Imaging, 29(4), 753-764. https://doi.org/10.1007/s10554-012-0136-z

Mischke, K., Knackstedt, C., Marx, N., & Vollmann, D. (2013). Insights into atrial fibrillation. Minerva Medica, 104(2), 119-130.

Camporeale, A., Marino, F., Papageorgiou, A., Carai, P., Fornero, S., Fletcher, S., Page, B. D. G., Gunning, P., Forni, M., Chiarle, R., Morello, M., Jensen, O., Levi, R., Heymans, S., & Poli, V. (2013). STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy. EMBO Molecular Medicine, 5(4), 572-590. https://doi.org/10.1002/emmm.201201876

Kaufmann, B. A., Min, S. Y., Goetschalckx, K., Bernheim, A. M., Buser, P. T., Pfisterer, M. E., & Brunner-La Rocca, H.-P. (2013). How reliable are left ventricular ejection fraction cut offs assessed by echocardiography for clinical decision making in patients with heart failure?International Journal of Cardiovascular Imaging, 29(3), 581-588. https://doi.org/10.1007/s10554-012-0122-5

Leptidis, S., el Azzouzi, H., Lok, S. I., de Weger, R., Olieslagers, S., Kisters, N., Silva, G. J., Heymans, S., Cuppen, E., Berezikov, E., De Windt, L. J., & Martins, P. D. C. (2013). A Deep Sequencing Approach to Uncover the miRNOME in the Human Heart. PLOS ONE, 8(2), Article e57800. https://doi.org/10.1371/journal.pone.0057800

Arends, S. J., Damoiseaux, J. G., Duijvestijn, A. M., Debrus-Palmans, L., Boomars, K. A., Brunner-La Rocca, H. P., Tervaert, J. W., & van Paassen, P. (2013). Functional implications of IgG anti-endothelial cell antibodies in pulmonary arterial hypertension. Autoimmunity, 46(7), 463-470. https://doi.org/10.3109/08916934.2013.812080

Smulders, M. W., Kietselaer, B. L. J. H., Das, M., Wildberger, J. E., Crijns, H. J. G. M., Veenstra, L., Brunner La Rocca, H. P., van Dieijen-Visser, M. P., Mingels, A. M. A., Dagnelie, P. C., Post, M. J., Gorgels, A. P. M., van Asselt, A. D. I., Vogel, G., Schalla, S., Kim, R. J., & Bekkers, S. C. A. M. (2013). The role of cardiovascular magnetic resonance imaging and computed tomography angiography in suspected non-ST-elevation myocardial infarction patients: Design and rationale of the CARdiovascular Magnetic rEsoNance imaging and computed Tomography Angiography (CARMENTA) trial. American Heart Journal, 166(6), 968-975. https://doi.org/10.1016/j.ahj.2013.09.012

Chouinard-Pelletier, G., Jahnsen, E. D., & Jones, E. A. V. (2013). Increased shear stress inhibits angiogenesis in veins and not arteries during vascular development. Angiogenesis, 16(1), 71-83. https://doi.org/10.1007/s10456-012-9300-2

Jeger, R. V., Rocca, H. P. B.-L., Bertel, O., Kiowski, W., Pfisterer, M. E., & Kaiser, C. A. (2013). Stent Thrombosis after Coronary Stent Implantation: A Protective Effect of High-Dose Statin Therapy?Cardiology, 126(2), 115-121. https://doi.org/10.1159/000350822

van Empel, V. P. M., De Windt, L. J., & Martins, P. A. D. C. (2012). Circulating miRNAs: Reflecting or Affecting Cardiovascular Disease?Current Hypertension Reports, 14(6), 498-509. https://doi.org/10.1007/s11906-012-0310-7

Scharf, C., Ng, G. A., Wieczorek, M., Deneke, T., Furniss, S. S., Murray, S., Debruyne, P., Hobson, N., Berntsen, R. F., Schneider, M. A., Hauer, H. A., Halimi, F., Boveda, S., Asbach, S., Boesche, L., Zimmermann, M., Brigadeau, F., Taieb, J., Merkel, M., ... Boersma, L. V. A. (2012). European survey on efficacy and safety of duty-cycled radiofrequency ablation for atrial fibrillation. EP Europace, 14(12), 1700-1707. https://doi.org/10.1093/europace/eus188

Spruit, M. A., Maeder, M. T., Knackstedt, C., Ammann, P., Jeker, U., Uszko-Lencer, N., Kiencke, S., Pfisterer, M. E., Rickli, H., & Brunner La Rocca, H. P. (2012). Prognostic Value of Self-Reported Versus Objectively Measured Functional Capacity in Patients With Heart Failure Results From the TIME-CHF (Trial of Intensified Versus Standard Medical Therapy in Elderly Patients With Congestive Heart Failure). Journal of the American College of Cardiology, 60(20), 2125-2126. https://doi.org/10.1016/j.jacc.2012.08.968

Heggermont, W. A., & Heymans, S. (2012). MicroRNAs Are Involved in End-Organ Damage During Hypertension. Hypertension, 60(5), 1088-1093. https://doi.org/10.1161/HYPERTENSIONAHA.111.187104

Bourgonje, V. J. A., Schoenmakers, M., Beekman, J. D. M., van der Nagel, R., Houtman, M. J. C., Miedema, L. F., Antoons, G., Sipido, K., de Windt, L. J., van Veen, T. A. B., & Vos, M. A. (2012). Relevance of calmodulin/CaMKII activation for arrhythmogenesis in the AV block dog. Heart Rhythm, 9(11), 1875-1883.e2. https://doi.org/10.1016/j.hrthm.2012.07.023

Rickenbacher, P., Pfisterer, M., Burkard, T., Kiowski, W., Follath, F., Burckhardt, D., Schindler, R., & Rocca, H.-P. B.-L. (2012). Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study. European journal of heart failure, 14(11), 1218-1229. https://doi.org/10.1093/eurjhf/hfs113

Eurlings, L. W., van Wijk, S., van Kimmenade, R., Osinski, A., van Helmond, L., Vallinga, M., Crijns, H. J., van Dieijen-Visser, M. P., Brunner La Rocca, H. P., & Pinto, Y. M. (2012). Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: The marked (multi marker emergency dyspnea)-risk score. Journal of the American College of Cardiology, 60(17), 1668-1677. https://doi.org/10.1016/j.jacc.2012.06.040

Foulquier, S., Steckelings, U. M., & Unger, T. (2012). Impact of the AT(2) Receptor Agonist C21 on Blood Pressure and Beyond. Current Hypertension Reports, 14(5), 403-409. https://doi.org/10.1007/s11906-012-0291-6

Henderson-Toth, C. E., Jahnsen, E. D., Jamarani, R., Al-Roubaie, S., & Jones, E. A. V. (2012). The glycocalyx is present as soon as blood flow is initiated and is required for normal vascular development. Developmental Biology, 369(2), 330-9. https://doi.org/10.1016/j.ydbio.2012.07.009

Chouinard-Pelletier, G., Leduc, M., Guay, D., Coulombe, S., Leask, R. L., & Jones, E. A. V. (2012). Use of inert gas jets to measure the forces required for mechanical gene transfection. Biomedical Engineering Online, 11, 67. https://doi.org/10.1186/1475-925X-11-67

Al-Roubaie, S., Hughes, J. H., Filla, M. B., Lansford, R., Lehoux, S., & Jones, E. A. V. (2012). Time-lapse microscopy of macrophages during embryonic vascular development. Developmental Dynamics, 241(9), 1423-31. https://doi.org/10.1002/dvdy.23835

Totzeck, M., Hendgen-Cotta, U. B., Rammos, C., Frommke, L.-M., Knackstedt, C., Predel, H.-G., Kelm, M., & Rassaf, T. (2012). Higher endogenous nitrite levels are associated with superior exercise capacity in highly trained athletes. Nitric Oxide-Biology and Chemistry, 27(2), 75-81. https://doi.org/10.1016/j.niox.2012.05.003

Knackstedt, C., Becker, M., Mischke, K., Pauling, R., Rocca, H. P. B.-L., & Schauerte, P. (2012). A dedicated cardioversion unit for the treatment of atrial fibrillation. Reducing costs by optimizing processes. Herz, 37(5), 518-526. https://doi.org/10.1007/s00059-011-3546-0

Dennert, R., van Paassen, P., Wolffs, P., Bruggeman, C., Velthuis, S., Felix, S., van Suylen, R.-J., Crijns, H. J., Tervaert, J. W. C., & Heymans, S. (2012). Differences in Virus Prevalence and Load in the Hearts of Patients with Idiopathic Dilated Cardiomyopathy with and without Immune-Mediated Inflammatory Diseases. Clinical and Vaccine Immunology, 19(8), 1182-1187. https://doi.org/10.1128/CVI.00281-12

Hazebroek, M., Dennert, R., & Heymans, S. (2012). Idiopathic dilated cardiomyopathy: possible triggers and treatment strategies. Netherlands Heart Journal, 20(7-8), 332-335. https://doi.org/10.1007/s12471-012-0285-7

Timmers, S., Nabben, M., Bosma, M., van Bree, B., Lenaers, E., Van Beurden, D., Schaart, G., Westerterp-Plantenga, M. S., Langhans, W., Hesselink, M. K. C., Schrauwen-Hinderling, V. B., & Schrauwen, P. (2012). Augmenting muscle diacylglycerol and triacylglycerol content by blocking fatty acid oxidation does not impede insulin sensitivity. Proceedings of the National Academy of Sciences of the United States of America, 109(29), 11711-11716. https://doi.org/10.1073/pnas.1206868109

Corsten, M. F., Schroen, B., & Heymans, S. (2012). Inflammation in viral myocarditis: friend or foe?Trends in Molecular Medicine, 18(7), 426-437. https://doi.org/10.1016/j.molmed.2012.05.005

el Azzouzi, H., Leptidis, S., Bourajjaj, M., van Bilsen, M., Martins, P. A. D. C., & De Windt, L. J. (2012). MEK1 Inhibits Cardiac PPAR alpha Activity by Direct Interaction and Prevents Its Nuclear Localization. PLOS ONE, 7(6), Article e36799. https://doi.org/10.1371/journal.pone.0036799

Daamen, M. A. M. J., Hamers, J. P. H., Gorgels, A. P. M., Brunner-La Rocca, H. P., Tan, F. E. S., van Dieijen-Visser, M. P., & Schols, J. M. G. A. (2012). The prevalence and management of heart failure in Dutch nursing homes: design of a multi-centre cross-sectional study. BMC Geriatrics, 12, Article 29. https://doi.org/10.1186/1471-2318-12-29

Salic, K., & De Windt, L. J. (2012). MicroRNAs as Biomarkers for Myocardial Infarction. Current Atherosclerosis Reports, 14(3), 193-200. https://doi.org/10.1007/s11883-012-0238-z

Tivig, C., Dang, L., Brunner-La Rocca, H.-P., Oezcan, S., Duru, F., & Scharf, C. (2012). Duty-cycled unipolar/bipolar versus conventional radiofrequency ablation in paroxysmal and persistent atrial fibrillation. International Journal of Cardiology, 157(2), 185-191. https://doi.org/10.1016/j.ijcard.2010.12.010

Papageorgiou, A.-P., & Heymans, S. (2012). Interactions between the extracellular matrix and inflammation during viral myocarditis. Immunobiology, 217(5), 503-510. https://doi.org/10.1016/j.imbio.2011.07.011

Donners, M. M. P. C., Wolfs, I. M. J., Stoger, L. J., van der Vorst, E. P. C., Pottgens, C. C. H., Heymans, S., Schroen, B., Gijbels, M. J. J., & de Winther, M. P. J. (2012). Hematopoietic miR155 Deficiency Enhances Atherosclerosis and Decreases Plaque Stability in Hyperlipidemic Mice. PLOS ONE, 7(4), Article e35877. https://doi.org/10.1371/journal.pone.0035877

Papageorgiou, A.-P., Swinnen, M., Vanhoutte, D., VandenDriessche, T., Chuah, M., Lindner, D., Verhesen, W., de Vries, B., D'hooge, J., Lutgens, E., Westermann, D., Carmeliet, P., & Heymans, S. (2012). Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells. Cardiovascular Research, 94(1), 115-124. https://doi.org/10.1093/cvr/cvs077

Jin, Y., Kuznetsova, T., Thijs, L., Schmitz, B., Liu, Y., Asayama, K., Brand, S.-M., Heymans, S., Brand, E., Fagard, R., & Staessen, J. A. (2012). Association of Left Ventricular Mass With the AGTR1 A1166C Polymorphism. American Journal of Hypertension, 25(4), 472-478. https://doi.org/10.1038/ajh.2011.244

Martins, P. A. D. C., & De Windt, L. J. (2012). MicroRNAs in control of cardiac hypertrophy. Cardiovascular Research, 93(4), 563-572. https://doi.org/10.1093/cvr/cvs013

Schroen, B., & Heymans, S. (2012). Small but smart-microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing. Cardiovascular Research, 93(4), 605-613. https://doi.org/10.1093/cvr/cvr268

Muzzarelli, S., Maeder, M. T., Toggweiler, S., Rickli, H., Nietlispach, F., Julius, B., Burkard, T., Pfisterer, M. E., & Brunner-La Rocca, H.-P. (2012). Frequency and Predictors of Hyperkalemia in Patients >= 60 Years of Age With Heart Failure Undergoing Intense Medical Therapy. American Journal of Cardiology, 109(5), 693-698. https://doi.org/10.1016/j.amjcard.2011.10.027

Burkard, T., Kaiser, C. A., Brunner-La Rocca, H., Osswald, S., Pfisterer, M. E., & Jeger, R. V. (2012). Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial. Journal of Internal Medicine, 271(3), 257-263. https://doi.org/10.1111/j.1365-2796.2011.02423.x

Maeder, M. T., Rickli, H., Pfisterer, M. E., Muzzarelli, S., Ammann, P., Fehr, T., Hack, D., Weilenmann, D., Dieterle, T., Kiencke, S., Estlinbaum, W., & Brunner-La Rocca, H.-P. (2012). Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy. American Heart Journal, 163(3), 407-U353. https://doi.org/10.1016/j.ahj.2011.12.003

Devaux, Y., Vausort, M., Goretti, E., Nazarov, P. V., Azuaje, F., Gilson, G., Corsten, M. F., Schroen, B., Lair, M.-L., Heymans, S., & Wagner, D. R. (2012). Use of Circulating MicroRNAs to Diagnose Acute Myocardial Infarction. Clinical Chemistry, 58(3), 559-567. https://doi.org/10.1373/clinchem.2011.173823

Zellweger, M. J., Kaiser, C. A., Jeger, R. V., Brunner-La Rocca, H.-P., Buser, P. T., Bader, F., Mueller-Brand, J., & Pfisterer, M. E. (2012). Coronary Artery Disease Progression Late After Successful Stent Implantation. Journal of the American College of Cardiology, 59(9), 793-799. https://doi.org/10.1016/j.jacc.2011.11.024

Daskalopoulos, E. P., Janssen, B. J. A., & Blankesteijn, W. M. (2012). Myofibroblasts in the Infarct Area: Concepts and Challenges. Microscopy and Microanalysis, 18(1), 35-49. https://doi.org/10.1017/S143192761101227X

Heijman, J., Spätjens, R. L. H., Seyen, S. R. M., Lentink, V., Kuijpers, H. J. H., Boulet, I. R., de Windt, L. J., David, M., & Volders, P. G. A. (2012). Dominant-Negative Control of cAMP-Dependent I-Ks Upregulation in Human Long-QT Syndrome Type 1. Circulation Research, 110(2), 211–219. https://doi.org/10.1161/CIRCRESAHA.111.249482

Octavia, Y., Rocca, H. P. B.-L., & Moens, A. L. (2012). NADPH oxidase-dependent oxidative stress in the failing heart: From pathogenic roles to therapeutic approach. Free Radical Biology and Medicine, 52(2), 291-297. https://doi.org/10.1016/j.freeradbiomed.2011.10.482

van Wijk, S., Jacobs, L., Eurlings, L. W., van Kimmenade, R., Lemmers, R., Broos, P., Bekers, O., Prins, M. H., Crijns, H. J., Pinto, Y. M., van Dieijen-Visser, M. P., & Brunner-La Rocca, H. P. (2012). Troponin T Measurements by High-Sensitivity vs Conventional Assays for Risk Stratification in Acute Dyspnea. Clinical Chemistry, 58(1), 284-292. https://doi.org/10.1373/clinchem.2011.175976